Syntheses,Structures and Anticancer Activity of NNO‐Tridentate Schiff Base Copper(II) Complexes

A series of heteroleptic copper(II) complexes [Cu( ^R QYMP )(Py]] ( 1a ‐ 4d ) supported on NNO‐tridentate Schiff base ( ^R QYMP ‐H) and bipyridine (Py=bpy, a ; phen, b ; dpq, c ; dppz, d ) co‐ligands have been synthesized and characterized. X‐ray crystal structural studies of complexes 1b , 2c , 3d and 4a displays that these complexes are mononuclear with a distorted square pyramidal geometry around the copper center. Cytotoxicity results indicate that all of these complexes have much higher activity against HeLa, SCC15, BCC and Ca9‐22 cancer cell lines as compared to cisplatin. Further, copper complex bearing suitable bulky group Schiff base ligands with dppz co‐ligand could be considered in designing efficient metalbased anticancer agents.     

Interaction of Dipalmitoyl Phosphatidylcholine with n‐Hexadecanol in Monolayer and Liposome

The monolayer collapse behavior of n‐hexadecanol/dipalmitoyl phosphatidylcholine (DPPC) was investigated in this study at the air/water interface at 37 °C. Surface pressure variations with time for the mixed monolayers of DPPC with 20 mol% and 50 mol% n‐hexadecanol at corresponding collapse points were recorded by a Langmuir trough system. In addition, the interaction of n‐hexadecanol with a pure DPPC monolayer was identified by fluorescence microscopy (FM). The results demonstrated distinct differences between these systems; according to our observation, the higher the ratio of n‐hexadecanol to DPPC, the more nucleation domains can be induced. The FM images demonstrated that pronounced domain formation was associated with a longer relaxation time of the collapsed DPPC and DPPC/n‐hexadecanol monolayers, and the presence of n‐hexadecanol appeared to enhance the relaxation processes. The liposome was prepared by the thin‐film hydration method. The average diameter of DPPC and DPPC/n‐hexadecanol liposomes was investigated by dynamic light scattering. It is shown that the diameter of DPPC liposome with n‐hexadecanol is smaller than pure DPPC liposome at the initial state. After 24 hours, DPPC/n‐hexadecanol liposome became larger than pure DPPC liposome and lasted for the next four days. The effects of a greater ratio of n‐hexadecanol did not play an important role in DPPC liposome formation based on our dynamic light scattering analysis. Our result demonstrated that n‐hexadecanol might affect the DPPC liposome stability. The increased ratio of n‐hexadecanol in DPPC liposomes could only a play a minor role in DPPC liposome fusion.     

Diacetatobis­(tri­methyl­ene­thio­urea)­zinc(II) monohydrate

In the title compound, [Zn(CH₃COO)₂(C₄H₈N₂S)₂]·H₂O, the Zn atom is tetrahedrally coordinated in the ZnO₂S₂ form. N—H?O and O—H?O intramolecular and intermolecular hydrogen bonds are formed by the four N atoms and the water mol­ecule. N—H?O intermolecular hydrogen bonds and C—H?S and C—H?O intermolecular interactions interconnect columns formed by the mol­ecules into layers. Adjacent layers are then linked by other N—H?O and O—H?O intermolecular hydrogen bonds to form a three‐dimensional framework throughout the structure. The orientations of the acetate planes are such that the Zn atom lies within them.     

On the matching polynomials of graphs with small number of cycles of even length

Suppose that G is a simple graph. We prove that if G contains a small number of cycles of even length then the matching polynomial of G can be expressed in terms of the characteristic polynomials of the skew adjacency matrix A(G^e) of an arbitrary orientation G^e of G and the minors of A(G^e). In addition to a formula previously discovered by Godsil and Gutman, we obtain a different formula for the matching polynomial of a general graph. © 2005 Wiley Periodicals, Inc. Int J Quantum Chem, 2005     

Bis(2‐amino­pyridine‐N)­bis­(benzoato‐O)­zinc

The crystal structure of the title compound, [Zn‐(C₇H₅O₂)₂(C₅H₆N₂)₂], is built of monomeric [Zn(2‐apy)₂(OBz)₂] mol­ecules (apy is amino­pyridine and OBz is benzoate). The Zn atom lies on a twofold symmetry axis and adopts a slightly distorted tetrahedral coordination. The Zn?O distances to the non‐coordinated O atoms are long at 2.872 (3) Å. Each non‐ligating carbonyl O atom of the benzoate anion accepts one intramolecular and one intermolecular hydrogen bond from the amino group. The mol­ecules form a chain along the c axis through intermolecular N—H?O hydrogen bonds between the amino and carboxyl groups.     

Multiwalled Carbon Nanotubes Encased in Ruthenium Oxide Film as a Hybrid Material for Neurotransmitters Sensor

A hybrid film (MWCNTs‐RuO_x?nH₂O) which contains multiwalled carbon nanotubes (MWCNTs) along with the incorporation of ruthenium oxide (RuO_x?nH₂O) has been synthesized on glassy carbon electrode (GCE), gold (Au), indium tin oxide (ITO) and screen printed carbon electrode (SPCE) by potentiostatic methods. The presence of MWCNTs in the hybrid film enhances surface coverage concentration (Γ) of RuO_x?nH₂O to ≈2100%. The surface morphology of the hybrid film deposited on ITO has been studied using scanning electron microscopy and atomic force microscopy. These two techniques reveal that the RuO_x?nH₂O incorporated on MWCNTs. Electrochemical quartz crystal microbalance study too reveals the incorporation of MWCNTs and RuO_x?nH₂O. The MWCNTs‐RuO_x?nH₂O hybrid film exhibits promising enhanced electrocatalytic activity towards the biochemical compounds such as epinephrine and norepinephrine. The electrocatalytic responses of these analytes at RuO_x?nH₂O, MWCNTs and MWCNTs‐RuO_x?nH₂O hybrid films have been measured using cyclic voltammetry. The obtained sensitivity values from electrocatalysis studies of analytes for MWCNTs‐RuO_x?nH₂O hybrid film are higher than the RuO_x?nH₂O and MWCNTs films. Finally, the flow injection analysis has been used for the amperometric studies of analytes at MWCNTs‐RuO_x?nH₂O hybrid film modified SPCEs.     

Metabolic activities affect femur and lumbar vertebrae remodeling,and anti-resorptive risedronate disturbs femoral cortical bone remodeling

Metabolic activities are closely correlated with bone remodeling and long-term anti-resorptive bisphosphonate treatment frequently causes atypical femoral fractures through unclear mechanisms. To explore whether metabolic alterations affect bone remodeling in femurs and lumbar vertebrae and whether anti-osteoporotic bisphosphonates perturb their reconstruction, we studied three mouse strains with different fat and lean body masses (BALB/c, C57BL6, and C3H mice). These mice displayed variable physical activity, food and drink intake, energy expenditure, and respiratory quotients. Following intraperitoneal calcein injection, double calcein labeling of the femoral diaphysis, as well as serum levels of the bone-formation marker procollagen type-I N-terminal propeptide and the bone-resorption marker C-terminal telopeptide of type-I collagen, revealed increased bone turnover in mice in the following order: C3H > BALB/c ≥ C57BL6 mice. In addition, bone reconstitution in femurs was distinct from that in lumbar vertebrae in both healthy control and estrogen-deficient osteoporotic mice with metabolic perturbation, particularly in terms of femoral trabecular and cortical bone remodeling in CH3 mice. Interestingly, subcutaneous administration of bisphosphonate risedronate to C3H mice with normal femoral bone density led to enlarged femoral cortical bones with a low bone mineral density, resulting in bone fragility; however, this phenomenon was not observed in mice with ovariectomy-induced femoral cortical bone loss. Together, these results suggest that diverse metabolic activities support various forms of bone remodeling and that femur remodeling differs from lumbar vertebra remodeling. Moreover, our findings imply that the adverse effect of bisphosphonate agents on femoral cortical bone remodeling should be considered when prescribing them to osteoporotic patients.Subject terms: Bone, Bone quality and biomechanics     

Betulinic Acid Restricts Human Bladder Cancer Cell Proliferation In Vitro by Inducing Caspase-Dependent Cell Death and Cell Cycle Arrest,and Decreasing Metastatic Potential

Betulinic acid (BA) is a naturally occurring pentacyclic triterpenoid and generally found in the bark of birch trees (Betula sp.). Although several studies have been reported that BA has diverse biological activities, including anti-tumor effects, the underlying anti-cancer mechanism in bladder cancer cells is still lacking. Therefore, this study aims to investigate the anti-proliferative effect of BA in human bladder cancer cell lines T-24, UMUC-3, and 5637, and identify the underlying mechanism. Our results showed that BA induced cell death in bladder cancer cells and that are accompanied by apoptosis, necrosis, and cell cycle arrest. Furthermore, BA decreased the expression of cell cycle regulators, such as cyclin B1, cyclin A, cyclin-dependent kinase (Cdk) 2, cell division cycle (Cdc) 2, and Cdc25c. In addition, BA-induced apoptosis was associated with mitochondrial dysfunction that is caused by loss of mitochondrial membrane potential, which led to the activation of mitochondrial-mediated intrinsic pathway. BA up-regulated the expression of Bcl-2-accociated X protein (Bax) and cleaved poly-ADP ribose polymerase (PARP), and subsequently activated caspase-3, -8, and -9. However, pre-treatment of pan-caspase inhibitor markedly suppressed BA-induced apoptosis. Meanwhile, BA did not affect the levels of intracellular reactive oxygen species (ROS), indicating BA-mediated apoptosis was ROS-independent. Furthermore, we found that BA suppressed the wound healing and invasion ability, and decreased the expression of Snail and Slug in T24 and 5637 cells, and matrix metalloproteinase (MMP)-9 in UMUC-3 cells. Taken together, this is the first study showing that BA suppresses the proliferation of human bladder cancer cells, which is due to induction of apoptosis, necrosis, and cell cycle arrest, and decrease of migration and invasion. Furthermore, BA-induced apoptosis is regulated by caspase-dependent and ROS-independent pathways, and these results provide the underlying anti-proliferative molecular mechanism of BA in human bladder cancer cells.